StaiMune® (Inactivated Bacillus coagulans GBI-30 — Kerry)

Evidence Level
Preliminary
3 Clinical Trials
2 Documented Benefits
1/5 Evidence Score

StaiMune® is an inactivated (heat-killed) form of Bacillus coagulans GBI-30, 6086, the same strain sold live as BC30. Because the cells are no longer alive, it is classed as a postbiotic rather than a probiotic. In a laboratory study sponsored by Ganeden, the strain's original owner, the inactivated cells activated human immune cells and raised both immune-activating and calming signaling proteins. Two small placebo-controlled trials have tested it by mouth. In 16 healthy young men, white blood cell counts shortly after hard exercise were higher than with placebo, but most immune measures did not differ between groups. In 16 soldiers in training, no performance or blood measure differed significantly from placebo. The human evidence is therefore early and mostly unconfirmed.

Studied Dose Two small trials have tested it by mouth: 50 mg (about 500 million inactivated cells) a day for 28 days, and about 1 billion inactivated cells a day for 2 weeks. Follow the label of the finished product.
Active Compound Inactivated (heat-killed) Bacillus coagulans GBI-30, 6086 cells, a postbiotic. Laboratory work suggests cell wall parts such as lipoteichoic acid stay intact after inactivation.

Benefits

Immune markers after strenuous exercise

In a 28-day pilot in 16 healthy young men, white blood cell counts 10 minutes after hard exercise were higher than with placebo, and salivary IgA held up in both groups, but most other immune measures changed only within the treated group. In a 2-week trial in 16 soldiers, IL-10 and IFN-gamma changes only trended (p = 0.057) and no blood measure differed from placebo.

Immune cell activity in laboratory tests

When researchers added inactivated cells to human immune cells from healthy donors, T cells, NK cells and NKT cells showed signs of activation, and the cells released more of both immune-activating and anti-inflammatory signaling proteins. This was a single laboratory study funded by the strain's owner.

Mechanism of action

1

Immune cell activation in a dish

In cell culture, inactivated cells raised the early activation marker CD69 on several types of immune cells and increased IL-6, TNF-alpha and IFN-gamma along with the anti-inflammatory IL-10 and IL-1ra and the growth factor G-CSF. Whether this happens when the ingredient is swallowed is unknown.

2

Cell wall parts survive heat treatment

The study authors suggest that immune-signaling parts of the cell wall, such as lipoteichoic acid, are not damaged by inactivation, which would explain why dead cells still triggered responses in the laboratory.

Clinical trials

1
Inactivated Bacillus coagulans GBI-30, 6086 and human immune cells (laboratory study)
PubMed

In vitro study: blood immune cells from healthy donors were cultured with inactivated GBI-30, 6086 cells for 24 hours. Three authors were employees of the sponsor, Ganeden. (Jensen et al. 2017, J Inflamm Res)

Human immune cells in a laboratory dish; no people took the ingredient.

The inactivated cells activated T, NK and NKT cells and raised both immune-activating cytokines (IL-1 beta, IL-6, IL-17A, TNF-alpha, IFN-gamma) and anti-inflammatory ones (IL-10, IL-1ra), plus G-CSF. These are laboratory results and do not show a benefit in people.

2
StaiMune and immune markers after strenuous exercise
PubMed

Randomized, double-blind, placebo-controlled pilot; 50 mg StaiMune (about 500 million inactivated cells) or placebo daily for 28 days, with immune markers measured at rest and after a hard treadmill session. Not PubMed-indexed. (Kalman et al. 2018, J Probiotics Health)

16 healthy young men, average age about 23 (14 completed per protocol).

Ten minutes after exercise, white blood cell counts were higher with StaiMune than with placebo, and salivary IgA was maintained in both groups. Most other immune changes were seen only within the StaiMune group rather than as differences from placebo. No serious adverse events were reported.

3
Inactivated Bacillus coagulans during military training
PubMed

Randomized, double-blind, placebo-controlled trial over 2 weeks. The abstract does not name the strain; a 2024 systematic review identifies it as inactivated GBI-30, 6086 at about 1 billion cells a day. (Hoffman et al. 2019, J Strength Cond Res)

16 male soldiers on the same self-defense training course (8 per group).

No performance or blood measure changed significantly compared with placebo. Vertical jump power (p = 0.089) and IL-10 and IFN-gamma (both p = 0.057) only trended. Using magnitude-based inference, the authors described the jump power and casualty drag changes as likely beneficial.

Side effects and drug interactions

Common Potential side effects

No serious adverse events were reported in a 28-day pilot in 16 healthy men; longer use has not been studied.
Mild digestive changes are possible when starting any gut supplement.
The cells are inactivated, so they are not expected to grow in the gut the way live probiotics can.

Important Drug interactions

Immunosuppressant drugs: in the laboratory it activated immune cells, so ask your doctor before use.
No drug interactions have been studied.
Tell your doctor if you are immunocompromised.

Frequently asked questions about StaiMune® (Inactivated Bacillus coagulans GBI-30 — Kerry)

What is StaiMune?

StaiMune® is an inactivated (heat-killed) form of Bacillus coagulans GBI-30, 6086, the same strain sold live as BC30. Because the cells are no longer alive, it is classed as a postbiotic rather than a probiotic.

What is StaiMune used for?

StaiMune is researched primarily for Immune Support. In a 28-day pilot in 16 healthy young men, white blood cell counts 10 minutes after hard exercise were higher than with placebo, and salivary IgA held up in both groups, but most other immune measures changed only within the treated group.

What is the recommended dosage of StaiMune?

The clinically studied dose is Two small trials have tested it by mouth: 50 mg (about 500 million inactivated cells) a day for 28 days, and about 1 billion inactivated cells a day for 2 weeks. Follow the label of the finished product. Always follow the product label and check with a healthcare provider for personal advice.

Is StaiMune safe, and does it have side effects?

Side effects and cautions reported for StaiMune include: No serious adverse events were reported in a 28-day pilot in 16 healthy men; longer use has not been studied. Mild digestive changes are possible when starting any gut supplement. It may also interact with some medications. StaiMune is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does StaiMune interact with any medications?

Possible interactions include: Immunosuppressant drugs: in the laboratory it activated immune cells, so ask your doctor before use. No drug interactions have been studied. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for StaiMune?

NutraSmarts rates the evidence for StaiMune as Preliminary (1 out of 5). It is backed by 3 study summaries and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Jensen GS, Cash HA, Farmer S, Keller D. Inactivated probiotic Bacillus coagulans GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro. J Inflamm Res. 2017;10:107-117. doi: 10.2147/JIR.S141660.PubMedUsed to support: In vitro study: inactivated B. coagulans GBI-30, 6086 (StaiMune) cells activated human T, NK and NKT cells and increased both immune-activating and anti-inflammatory cytokines and G-CSF. No people took the ingredient. Three authors were employees of the sponsor, Ganeden.
  2. Kalman DS, Hewlings S. Inactivated Probiotic Bacillus coagulans GBI-30 Demonstrates Immunosupportive Properties in Healthy Adults Following Stressful Exercise. J Probiotics Health. 2018;6(1):190. doi: 10.4172/2329-8901.1000190.SourceUsed to support: Not PubMed-indexed (read on the publisher site). Randomized, double-blind, placebo-controlled pilot in 16 healthy young men taking 50 mg StaiMune (about 500 million inactivated cells) or placebo for 28 days. White blood cell counts 10 minutes after strenuous exercise were higher than with placebo and mucosal immunity was maintained in both groups; most other changes were within-group only. No serious adverse events.
  3. Hoffman JR, Hoffman MW, Zelicha H, Gepner Y, Willoughby DS, Feinstein U, Ostfeld I. The Effect of 2 Weeks of Inactivated Probiotic Bacillus coagulans on Endocrine, Inflammatory, and Performance Responses During Self-Defense Training in Soldiers. J Strength Cond Res. 2019;33(9):2330-2337. doi: 10.1519/JSC.0000000000003265.PubMedUsed to support: Randomized, double-blind trial in 16 male soldiers: 2 weeks of inactivated B. coagulans or placebo produced no significant changes in any performance or blood measure; jump power (p = 0.089) and IL-10 and IFN-gamma (p = 0.057) only trended.
  4. Kerksick CM, Moon JM, Jäger R. It's Dead! Can Postbiotics Really Help Performance and Recovery? A Systematic Review. Nutrients. 2024;16(5):720. doi: 10.3390/nu16050720.PubMedUsed to support: Systematic review of postbiotics in exercise. It identifies the inactivated B. coagulans in the 2019 soldier trial as GBI-30, 6086 at 1 billion cells a day for 14 days, and summarizes the 28-day pilot of 50 mg inactivated GBI-30, 6086 in 16 healthy men.